Tumor Treating Fields mesothelioma natural treatment
Fields mesothelioma treating tumors, a new form of therapy, uses alternating electric field to slow the growth of cancer. It is combined with chemotherapy to treat mesothelioma pleural.
The FDA approved TTFields together with pemetrexed as well as cisplatin in 2019 after the successful STELLAR trial. Patients can ask their specialist for this treatment.
Disrupting Cell Division
TTFields uses different electrical fields that disrupt cancer cell protein and prevent the cells from dividing. This prevents mesothelioma tumor cells from advancing or spreading to other organs in the body. The TTFields can also stimulate the production of proteins that eliminate cancer cells and aid the immune system fight mesothelioma tumors.
During treatment patients wear a small device that contains pads insulated with adhesive that adhere to the skin. The device is able to deliver a low-intensity electrical current, and patients are able to decide the extent of treatment they receive. The duration of a mesothelioma treatment of peritoneal mesothelioma typically lasts 30 minutes. Patients can have TTFields treatment several times per day.
A TTFields study from 2021 found that electrical fields ranging from 100 to 300 kilohertz were able to stop cancer cell division and cause them to die. The study included a variety of of cancer cells and found that electrical fields killed all of them regardless of their cellular structure.
The study’s author recommended the use of TTFields with chemotherapy for mesothelioma. FDA approved Novocure’s TTFields NovoTTF 100L in the year 2019 for the treatment of unresectable pleural msothelioma. It is now accessible through mesothelioma doctors at certified medical centers across the U.S., including the West Cancer Center in Memphis. The NovoTTF-100L device, which is now known as Optune Lua, has been used to treat mesothelioma in combination with pemetrexed and platinum-based chemotherapy. Patients with mesothelioma have reported a longer survival time when the TTFields therapy is combined with chemotherapy.
Another study, published in “Lung Cancer”, reported that TTFields therapy is effective when combined with chemotherapy. Researchers found that combing chemotherapy with TTFields significantly reduced the amount of mesothelioma tumors that are malignant in animal models. The study also showed combing these treatments boosted the production proteins that kill mesothelioma cancer cells and reduce the amount or cancerous DNA found in your body.
The TTFields treatment for mesothelioma lung cancer is a relatively new treatment and many mesothelioma doctors do not recommend it for pleural malignant mesothelioma. Patients may still have access to this treatment through clinical trials or at clinics that are certified by Novocure for Biphasic Mesothelioma Treatment (Https://Mesotheliomatreatment37650.Blogadvize.Com/27619606/11-Ways-To-Completely-Revamp-Your-Mesothelioma-Stage-4-Treatment).
Stalling Tumor Development
Mesothelioma forms when mesothelial cells alter and exceed their normal lifespan, leading to an abundance of diseased cells that grow and spread in the body. Tumor treatment fields prevent mesothelial cells from duplication and prevent mesothelioma growing and spreading.
The TTFields device is worn on the chest similar to the vest, and creates an array of electrical fields that can destroy proteins which kill cancerous cells and slow down the growth of tumors. The device comes with an insulated pad that sticks to the skin and can be applied at the home of patients or health professionals trained by Novocure.
Doctors suggest the combination of TTFields therapy with chemotherapy for the best results. The combination boosts the production of proteins which destroy cancer cells and reduces cancer cells’ ability to repair DNA damage from chemotherapy drugs. This allows the chemotherapies to perform more effectively and increases the survival rate of mesothelioma patients.
In the most recent STELLAR trial, the combination of TTFields therapy and chemotherapy significantly increased survival in mesothelioma victims. The FDA approved the NovoTTF-100L system, which is now marketed as Optune Lua, for use in conjunction with pemetrexed and cisplatin or carboplatin as first-line treatment for malignant pleural mesothelioma in 2019.
Researchers have found that the TTFields treatment works against mesothelioma through preventing cell division. The TTFields therapy causes cancer cells to split during a process known as mitosis. The cellular debris is absorbed by surrounding tissues and blocks the growth of new mesothelioma treatment options tissue. Mitosis stops mesothelioma tumor cells from repair of damaged genetic material and makes them more prone to radiation therapy.
The TTFields treatment may also reduce tumor blood flow by reducing vascular endothelial growth factor, also known as VEGF, as well as increasing hypoxia-inducible factor-1 alpha, or HIF-1a. This is associated with cancer cell angiogenesis.
Speak to your doctor if you have been diagnosed with mesothelioma. Many mesothelioma specialists are collaborating with Novocure on clinical trials to evaluate the effectiveness of this innovative treatment. To learn more about how mesothelioma-TTFields might help your treatment plan get in touch with a Novocure certified specialist at one of the more than 1,300 U.S. treatment centers.
Killing Tumor Cells
Tumor treating fields (TTFields) disrupt cell division by sending electrical waves through the body to destroy cancer cells. TTFields are low-intensity and intermediate frequency electric fields that alternately target cancerous cells without harming healthy ones. These electric fields also reduce DNA repair and boost cellular defenses to make it more difficult for cancerous cells to survive. TTF is an effective treatment that is non-invasive and has only a few adverse effects, besides mild skin irritation.
Scientists believe TTFields function by disrupting mitosis, the process where the cell divides into two identical new cells. Normal cells have control mechanisms in place to limit the rate of mitosis but cancerous malignant cells breach this control and multiply in a rapid rate. TTFields interferes with this process by blocking the signals that regulate the process of mitosis in mesothelioma cancer cells. In the STELLAR study TTFields when combined with chemotherapy significantly increased survival rates for mesothelioma patients. Mesothelioma patients who received TTFields along with maintenance cycles of chemotherapy survived six months longer than those who received only chemotherapy.
A separate study has found that TTFields could boost the effectiveness of certain chemotherapy drugs called platinum-based therapies. These platinum-based therapies destroy mesothelioma by targeting mitochondria. This is where the energy of cancerous cells originates. When TTFields are used in combination with these chemotherapy treatments, it could result in more DNA damage, and faster death of cancer cells.
TTFields may also boost the effects of radiation therapy in certain instances. Researchers have discovered that combining TTFields with radiation therapy may cause a “synergistic effect.” This means that the combined treatments increase the sensitivity of mesothelioma cancer cells to radiation.
The TTFields treatment is currently only available in certain mesothelioma centres. A mesothelioma expert can determine if you’re eligible for this treatment. If you qualify, a lawyer for mesothelioma can assist you in obtaining treatment that incorporates TTFields along with chemotherapy. If you are an veteran, a mesothelioma lawyer can help you access treatment that is covered under your VA health benefits.
Side Effects
The TT fields therapy destroys cancer cells by creating a field of electricity that interferes with their ability to divide. This may slow the growth of a tumor and stop it from spreading to other parts of the body. The TT fields device is non-invasive, which means it does not damage the surrounding tissue or cause discomfort. This is different from traditional chemotherapy, which requires injections into the vein or radiation, macphearson.org both of which can cause serious side effects.
In a study in which patients were treated with a combination TT fields and temozolomide showed survival improvements similar to those who were treated only with chemo. Doctors attributed this increased survival to TT fields, which enhance the efficacy of chemotherapy while minimizing side effects.
Mesothelioma cells can mutate into cancerous cells, and then reproduce in uncontrolled ways to create a tumor that invades the organs of your body. By disrupting the division of cells, [Redirect-302] mesothelioma therapies like TT fields stop mesothelioma cells from reproducing and hindering the body’s normal functions.
In a mesothelioma research study patients who received TT-fields together with chemotherapy had an average survival rate (18.2 months). Those who treats mesothelioma were given TT fields without chemo had a median survival of 12.1 months.
Tumor-treating fields are applied to the pleura, or the thin lining of your lungs, whether on your abdomen or chest wall. The device is small enough to be worn for up to 18 hours each day, including sleep. Patients can carry on their normal life and work even while they undergo treatment.
TT fields can be incorporated with traditional chemotherapy or immunotherapy as well as other mesothelioma treatment options. Patients with mesothelioma who are interested in TT fields should discuss this option with their mesothelioma physician, who can explain the eligibility requirements and advantages for each patient’s specific case.